A07582 Summary:

BILL NOA07582
 
SAME ASSAME AS S05403
 
SPONSORMcDonald
 
COSPNSRD'Urso, Sayegh, Dickens, Seawright, Morinello, DeStefano, Montesano, Griffin, Lawrence, Mikulin, Schmitt, Ashby, Finch, Crouch
 
MLTSPNSR
 
Add §6808-c, Ed L
 
Requires manufacturer of nonprescription blood glucose self-testing equipment, devices and supplies to submit to the New York State Board of Pharmacy a comprehensive list of designated suppliers and authorized distributors of nonprescription blood glucose self-testing equipment, devices and supplies; and prohibits pharmacists from distributing nonprescription blood glucose self-testing equipment, devices, and supplies or seeking reimbursement therefor when the pharmacist knows or has reason to know that the equipment did not come through an authorized supplier or distributor.
Go to top    

A07582 Actions:

BILL NOA07582
 
05/09/2019referred to higher education
01/08/2020referred to higher education
Go to top

A07582 Committee Votes:

Go to top

A07582 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A07582 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          7582
 
                               2019-2020 Regular Sessions
 
                   IN ASSEMBLY
 
                                       May 9, 2019
                                       ___________
 
        Introduced by M. of A. McDONALD -- read once and referred to the Commit-
          tee on Higher Education
 
        AN  ACT  to amend the education law, in relation to designated suppliers
          and authorized distributors of  nonprescription  blood  glucose  self-
          testing equipment, devices and supplies

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The education law is amended by adding a new section 6808-c
     2  to read as follows:
     3    § 6808-c. Suppliers and  authorized  distributors  of  nonprescription
     4  blood  glucose  self-testing equipment, devices and supplies. 1. As used
     5  in this section, "nonprescription blood glucose self-testing  equipment,
     6  devices  and  supplies" means blood glucose monitors, continuous glucose
     7  monitors (CGM), blood glucose test strips, lancet devices  and  lancets,
     8  glucose control solutions for checking the accuracy of testing equipment
     9  and  test  strips,  supply  allowance for therapeutic continuous glucose
    10  monitors (CGM), including all supplies and accessories for  use  in  the
    11  treatment  of prediabetic or diabetic individuals that may be sold with-
    12  out a prescription and are labeled for use by the consumer in accordance
    13  with the requirements of the laws and rules of this state and the feder-
    14  al government.
    15    2. Within one hundred eighty  days  of  the  effective  date  of  this
    16  section, each manufacturer of nonprescription blood glucose self-testing
    17  equipment, devices and supplies shall submit to the state board of phar-
    18  macy  a  comprehensive  list  of  designated  suppliers  and  authorized
    19  distributors of nonprescription blood  glucose  self-testing  equipment,
    20  devices and supplies. Such manufacturers shall update the state board of
    21  pharmacy  when there are any changes to the list of designated suppliers
    22  and authorized distributors. Within ninety days of receiving that infor-
    23  mation, such board shall post the  names  of  designated  suppliers  and
    24  authorized distributors on the department's website.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD11356-01-9

        A. 7582                             2
 
     1    3. It shall be unprofessional conduct for a pharmacist to:
     2    a.  dispense  nonprescription  blood  glucose  self-testing equipment,
     3  devices and supplies received from a person or entity that  the  pharma-
     4  cist  knew  or  reasonably  should  have  known was not a manufacturer's
     5  designated supplier or authorized distributor; or
     6    b. submit a reimbursement  claim  for  nonprescription  blood  glucose
     7  self-testing equipment, devices and supplies to a pharmaceutical benefit
     8  manager,  health  insurer, government agency, or other third-party payor
     9  when the pharmacist knew  or  reasonably  should  have  known  that  the
    10  diabetes test device was not purchased either directly from the manufac-
    11  turer  or from the nonprescription blood glucose self-testing equipment,
    12  devices and supplies manufacturer's designated  supplier  or  authorized
    13  distributor.
    14    § 2. This act shall take effect immediately.
Go to top